(secondQuint)Bioequivalence Study of Dr.

Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions.

 The objective of this study is to compare the rate and extent of absorption of fexofenadine hydrochloride 180 mg tablets (test) versus Allegra(R) (reference) administered as 1 x 180 mg tablet under fasting conditions.

 Single oral dose (1 x 180 mg) in each period with a washout of at least 7 days between doses.

.

 Bioequivalence Study of Dr.

Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions@highlight

Randomized, 2-Way Crossover, Bioequivalence Study of Fexofenadine Hydrochloride 180 mg Tablets of Dr.

Reddy's Laboratories Limited, and Allegra(R) 180 mg Tablets, Aventis Administered as 1 x 180 mg Tablet in Healthy Subjects under Fasting Conditions